Spotlight on valsartan-sacubitril fixed-dose combination for heart failure: the evidence to date
about
Hypertension in Patients with Heart Failure with Reduced Ejection Fraction.Effect of the angiotensin receptor neprilysin inhibitor sacubitril/valsartan on pharmacokinetics and pharmacodynamics of a single-dose of furosemide.Application and impact of run-in studies.Heterogeneous Pd catalysts as emulsifiers in Pickering emulsions for integrated multistep synthesis in flow chemistry.
P2860
Spotlight on valsartan-sacubitril fixed-dose combination for heart failure: the evidence to date
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Spotlight on valsartan-sacubit ...... failure: the evidence to date
@ast
Spotlight on valsartan-sacubit ...... failure: the evidence to date
@en
Spotlight on valsartan-sacubit ...... failure: the evidence to date
@nl
type
label
Spotlight on valsartan-sacubit ...... failure: the evidence to date
@ast
Spotlight on valsartan-sacubit ...... failure: the evidence to date
@en
Spotlight on valsartan-sacubit ...... failure: the evidence to date
@nl
prefLabel
Spotlight on valsartan-sacubit ...... failure: the evidence to date
@ast
Spotlight on valsartan-sacubit ...... failure: the evidence to date
@en
Spotlight on valsartan-sacubit ...... failure: the evidence to date
@nl
P2860
P921
P3181
P356
P1476
Spotlight on valsartan-sacubit ...... failure: the evidence to date
@en
P2093
José F. Vilela-Martin
P2860
P304
P3181
P356
10.2147/DDDT.S84782
P407
P5008
P577
2016-05-09T00:00:00Z